Innova Captab IPO
All details here!
Give a missed call
+91 99532 12345
All details here!
Overview of Innova Captab IPO
IPO Date
21-Dec-2023 to 26-Dec-2023
Face Value
Rs. 10 per share
Price Band
Rs. 426 to Rs. 448
Lot Size
33 Share
Issue Size
12723214 shares (aggregating up to Rs. 570.00 Cr)
Listing At
BSE, NSE
Basis of Allotment
27-Dec-2023
Initiation of Refunds
27-Dec-2023
Credit of Shares to Demat
27-Dec-2023
Listing Date
29-Dec-2023
Cut off time for UPI Mandate
27-Dec-2023
Objective of Innova Captab IPO
The company intends to use the net proceeds from the fresh issue for the following purposes:
1. Repaying and/or prepaying certain outstanding loans of the company.
2. Investing in the subsidiary, UML, for repaying and/or prepaying outstanding loans availed by UML.
3. Funding the working capital requirements.
4. General corporate purposes.
About Innova Captab IPO
Innova Captab Limited is a pharmaceutical company operating in three segments: contract development and manufacturing services, domestic branded generics, and international branded generics. Their product portfolio includes tablets, capsules, dry syrups, dry powder injections, ointments, and liquid medicines. In 2023, the company sold over 600 generics through its own brands in India and exported to 20 countries. They have a research and development lab with 29 scientists and a manufacturing facility in Buddi, Haryana. Innova Captab's customers include Cipla, Glenmark Pharmaceuticals, and Lupin. They have 200 active product registrations, 20 pending renewals, and 218 new registration applications being processed.
Innova Captab IPO Financials
Particulars (in Cr) | ||
---|---|---|
Total Revenue Annual | 867.41 | - |
Operating Expenses Annual | 0.00 | - |
Operating Profit Annual | - | - |
Depreciation | 10.66 | - |
Interest Annual | - | - |
Tax Annual | - | - |
Net Profit Annual | - | - |
Total Share Holder Funds | 276.51 | 208.61 |
Fixed Asset Annual | 187.73 | 166.37 |
Total Non Current Asset | 261.95 | 196.42 |
Total Current Asset | 442.47 | 379.05 |
Book Value Per Share | 55.90 | 1,756.89 |
ROE | 21.44% | 31.38% |
ROCE | 23.05% | 33.16% |
Total Debt To Total Equity | 0.88 | 0.84 |
EBIDTA | - | - |
Cash From Operating | 39.28 | 58 |
Cash From Investing | -87.53 | -188 |
Cash From Finance | 51.29 | 125 |
Net Cash Flow | 3.03 | -4 |
Promoter's Holding
Total Share Capital
33480000
Offered to Public
Promoter’s Holding(Pre-Issue)
66.85
Promoter’s Holding(Post-Issue)
The brokerage has assigned a 'Subscribe' rating to this IPO based on the company's strong presence and rapid growth in the Indian pharmaceutical formulations market, as well as its consistent financial performance. Additionally, the company is priced reasonably compared to its competitors.
The Innova Captab IPO is scheduled to be listed on both the BSE and NSE stock exchanges on December 29, 2023. The IPO has received a strong response from investors as it was highly oversubscribed. Investors can check the allotment status for the Innova Captab IPO.
Innova Captab is an integrated pharmaceutical company with a presence across the pharmaceuticals value chain, including research and development, manufacturing, drug distribution, marketing, and exports
Stock of the Month Announced!
Grab this investment opportunity today!